These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2548677)

  • 41. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
    Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
    Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
    J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study.
    Takita K; Herlenius EA; Lindahl SG; Yamamoto Y
    Brain Res; 1997 Dec; 778(1):233-41. PubMed ID: 9462896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonism of mu-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn.
    Dickenson AH; Knox RJ
    Neurosci Lett; 1987 Mar; 75(2):229-34. PubMed ID: 2883617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible selective blockade of kappa-opioid receptors in the guinea-pig ileum.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1986 Sep; 129(1-2):19-24. PubMed ID: 3021476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
    Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
    Passarelli F; Costa T
    J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
    Lupica CR; Proctor WR; Dunwiddie TV
    Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid peptides reduce synaptic transmission in the nucleus accumbens.
    Yuan XR; Madamba S; Siggins GR
    Neurosci Lett; 1992 Jan; 134(2):223-8. PubMed ID: 1317025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla.
    Fang FG; Haws CM; Drasner K; Williamson A; Fields HL
    Brain Res; 1989 Oct; 501(1):116-28. PubMed ID: 2572306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of mu opioid receptors in the pre-optic-anterior hypothalamus releases prolactin in the conscious male rat.
    Kapoor R; Willoughby JO
    Neuropeptides; 1991 Aug; 19(4):231-6. PubMed ID: 1681455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen suppresses mu-opioid- and GABAB-mediated hyperpolarization of hypothalamic arcuate neurons.
    Kelly MJ; Loose MD; Ronnekleiv OK
    J Neurosci; 1992 Jul; 12(7):2745-50. PubMed ID: 1319480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance.
    Kelly MJ; Loose MD; Ronnekleiv OK
    Neuroendocrinology; 1990 Sep; 52(3):268-75. PubMed ID: 2170854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo.
    Aimone LD; Yaksh TL
    Peptides; 1989; 10(6):1127-31. PubMed ID: 2482963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.